IDx avoids telehealth designation to improve market access

October 15, 2018 | Case Study

The U.S. Center for Medicaid and Medicare Services (CMS) sets the standard of reimbursement rates for medical services. Despite evolving standards of care across the telehealth space, the CMS routinely does not reimburse for telehealth, greatly limiting adoption. IDx, a company that develops tools to diagnose diabetic retinopathy without the aid of a trained specialist, has decided to forego the telehealth nomenclature for this reason, instead designating itself as a specialist health company. IDx is taking a unique approach in acquiring a U.S. FDA designation as specialty care despite telehealth applications to circumvent the lack of reimbursement and increase adoption by doctors.

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978